Insider trading

Period: 120 months Stock: IRWD Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

104 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

104 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

104 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

104 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
104 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
104 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

104 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Jul 2026
Silver Ronald PFO & PAO
Sold on a plan
$578.06K 127,890 at 4.52
29.0%
Planned (10b5-1)
17 Mar 2026
DENNER ALEXANDER J Director · indirect
Sold at will 2×
$20.53M 6,730,800 at 3.05
42.3%
Not planned
24 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$378.91K 103,526 at 3.66
6.5%
Not planned
23 Feb 2026
MCCOURT Thomas A Chief Executive Officer
Sold at will
$361.02K 94,757 at 3.81
5.6%
Not planned
5 Jan 2026
Silver Ronald Principal Accounting Officer
Sold on a plan
$162.91K 35,416 at 4.60
11.3%
Planned (10b5-1)
10 Feb 2025
MCCOURT Thomas A Chief Executive Officer
Sold at will
$244.75K 139,064 at 1.76
10.7%
Not planned
10 Jun 2024
McHugh Julie Director
Sold on a plan
$143.20K 22,766 at 6.29
14.0%
Planned (10b5-1)
7 Jun 2024
Sold at will
$235.14K 35,574 at 6.61
42.2%
Not planned
6 Jun 2024
Sold at will
$282.55K 44,426 at 6.36
34.5%
Not planned
20 May 2024
MCCOURT Thomas A Chief Executive Officer
Sold at will
$436.14K 67,618 at 6.45
5.6%
Not planned
20 May 2024
Davis Andrew SVP, Chief Business Officer
Sold at will
$146.58K 22,725 at 6.45
7.3%
Not planned
20 May 2024
John Minardo Chief Legal Officer
Sold at will
$112.26K 17,404 at 6.45
5.6%
Not planned
20 May 2024
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold at will
$104.03K 16,128 at 6.45
3.8%
Not planned
4 Mar 2024
Emany Sravan Kumar SVP, Chief Financial Officer
Bought
$100.22K 10,684 at 9.38
3.7%
12 Feb 2024
MCCOURT Thomas A Chief Executive Officer
Sold at will
$2.70M 177,164 at 15.24
17.5%
Not planned
12 Feb 2024
John Minardo Chief Legal Officer
Sold at will
$722.07K 47,380 at 15.24
17.4%
Not planned
12 Feb 2024
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold at will
$588.54K 38,618 at 15.24
10.2%
Not planned
12 Feb 2024
Davis Andrew SVP, Chief Business Officer
Sold at will
$150.05K 9,846 at 15.24
4.5%
Not planned
12 Feb 2024
Silver Ronald Principal Accounting Officer
Sold at will
$120.52K 7,908 at 15.24
5.6%
Not planned
14 Dec 2023
Kessler Marla L Director
Sold on a plan
$111.07K 9,926 at 11.19
9.3%
Planned (10b5-1)
15 Sep 2023
Emany Sravan Kumar SVP, Chief Financial Officer
Bought
$300.12K 36,072 at 8.32
23.6%
First buy on file
30 May 2023
MCCOURT Thomas A Chief Executive Officer
Sold on a plan
$284.96K 26,632 at 10.70
3.4%
Planned (10b5-1)
22 May 2023
MCCOURT Thomas A Chief Executive Officer
Sold at will
$364.32K 36,000 at 10.12
4.4%
Not planned
22 May 2023
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold at will
$104.48K 10,324 at 10.12
3.1%
Not planned
8 May 2023
MCCOURT Thomas A Chief Executive Officer
Sold at will
$224.59K 21,148 at 10.62
2.5%
Not planned
27 Mar 2023
MCCOURT Thomas A Chief Executive Officer
Sold at will
$492.20K 46,129 at 10.67
5.2%
Not planned
3 Mar 2023
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$378.74K 33,756 at 11.22
5.0%
28 Feb 2023
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated 2×
$353.18K 31,227 at 11.31
4.4%
28 Feb 2023
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated 2×
$197.12K 17,429 at 11.31
5.0%
28 Feb 2023
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold, plan not stated 2×
$111.45K 9,854 at 11.31
3.6%
27 Feb 2023
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated 2×
$342.35K 30,004 at 11.41
4.0%
27 Feb 2023
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated 2×
$191.07K 16,746 at 11.41
4.6%
27 Feb 2023
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold, plan not stated 2×
$108.03K 9,468 at 11.41
3.4%
5 Jan 2023
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$1.34M 110,962 at 12.07
13.5%
14 Dec 2022
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated
$334.53K 27,000 at 12.39
7.2%
3 Oct 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$196.74K 18,899 at 10.41
2.6%
1 Sep 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$281.65K 26,446 at 10.65
3.5%
11 Aug 2022
Currie Mark G Director
Sold, plan not stated
$824.60K 70,000 at 11.78
11.8%
9 Aug 2022
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated
$211.98K 18,041 at 11.75
4.6%
8 Aug 2022
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated 2×
$342.46K 29,436 at 11.63
7.2%
1 Aug 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$263.65K 23,229 at 11.35
3.0%
30 Jun 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated
$231.13K 19,959 at 11.58
2.5%
7 Jun 2022
Currie Mark G Director
Sold, plan not stated
$2.29M 190,383 at 12.01
24.3%
23 May 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated 3×
$417.54K 36,308 at 11.50
4.3%
23 May 2022
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated 2×
$155.68K 13,537 at 11.50
3.2%
23 May 2022
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold, plan not stated 2×
$121.70K 10,583 at 11.50
3.8%
14 Mar 2022
McHugh Julie Director
Sold, plan not stated
$233.40K 20,000 at 11.67
14.5%
28 Feb 2022
MCCOURT Thomas A Chief Executive Officer
Sold, plan not stated 4×
$521.53K 48,424 at 10.77
7.6%
28 Feb 2022
Rickard Jason SVP, Chief Operating Officer
Sold, plan not stated 5×
$311.92K 28,962 at 10.77
8.1%
28 Feb 2022
Shetzline Michael CMO,SVP,Head-Res&Drug
Sold, plan not stated 5×
$189.63K 17,607 at 10.77
8.3%
Showing 1–50 of 104. Page 1 of 3 Older →